Clinical Trial

Blood Biomarkers from Internal Jugular Vein for the Diagnosis of Alzheimer's Disease

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to explore the diagnostic performance of blood biomarkers from the internal jugular vein for the diagnosis of Alzheimer's disease (AD) in patients with cognitive symptoms or concerns. The main question it aims to answer is: Whether blood biomarkers from the internal jugular vein outperform those from the median cubital vein which is the routine site for venous blood collection?
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06754254
Lead Sponsor Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions Alzheimer Disease
Enrollment 300 participants
Start Date 2019-03-21
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-31